We chose to infect activated CD4 + T cells on later days post-activation (on day 7 rather than on day 3 peak activation) because there was a study showing infection on later days post-activation generated more latent infection [19]. The gene discussed is CD4; the disease is disease arising from reactivation of latent virus.